Named in more than 5,000 lawsuits because of its dangerous side effects, Accutane IBD lawsuits have awarded significant jury awards to plaintiffs. In June 2009, Roche Laboratories decided to remove Accutane from the market, citing loss of market share and acknowledged it was incurring increasing costs over Accutane litigation. A current Black Box warning on Accutane cautions consumers about its potential to harm unborn children. Additional serious side effects associated with Accutane use include depression, IBD, and liver disease.
In November 2008, a New Jersey jury ordered Roche to pay $13 million to three plaintiffs. The prior April, another NJ jury awarded $10.5 million to a woman who blamed the drug for her ulcerative colitis. In May 2007, a NJ trial resulted in an award of $2.62 million to a patient requiring removal of his colon and most of his rectum after taking Accutane. That October, a Florida jury awarded $7 million in damages to another Accutane user who developed IBD.
Bloomberg News reported that Roche lost all seven Accutane cases under consideration by juries since 2007, including the last three in a row. Juries in NJ and FL ordered Roche to pay at least $45 million in damages; however, appeals courts later threw out two of the verdicts, including a 2007 award of $7 million to a Florida man who blamed the drug for IBD.
Originially posted on Monday, November 22nd, 2010 at 10:46am at NewsInferno.com.